{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:50:14Z","timestamp":1791132614040,"version":"4.1.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.drudis.2014.04.014","type":"journal-article","created":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T13:16:58Z","timestamp":1398863818000},"page":"1410-1418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":165,"title":["Melatonin: functions and ligands"],"prefix":"10.1016","volume":"19","author":[{"given":"Mahaveer","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant R.","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2014.04.014_bib0005","first-page":"613","article-title":"Conversion of L-tryptophan to melatonin in the GIT: new HPLC method enabling simultaneous determination of six metabolites of L-tryptophan by native fluorescence and UV\u2013VIS detection","volume":"63","author":"Zagajewski","year":"2012","journal-title":"J. Phys. Pharmacol."},{"key":"10.1016\/j.drudis.2014.04.014_bib0010","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1023\/A:1020107915919","article-title":"Gastrointestinal melatonin: localization, function, and clinical relevance","volume":"47","author":"Bubenik","year":"2002","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.drudis.2014.04.014_bib0015","first-page":"739","article-title":"Effect of melatonin on human keratinocytes and fibroblasts subjected UVA and UVB radiation in vitro","volume":"23","author":"Ilona","year":"2009","journal-title":"In Vivo"},{"key":"10.1016\/j.drudis.2014.04.014_bib0020","first-page":"1","article-title":"Melatonin receptor MT1 is expressed in mouse skin and In vitro treatment enhances whisker growth","volume":"4","author":"Yoshida","year":"2013","journal-title":"J. Clin. Exp. Dermatol. Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00418-011-0800-8","article-title":"Expression and cellular localization of melatonin synthesizing enzymes in rat and human salivary glands","volume":"135","author":"Shimozuma","year":"2011","journal-title":"Histochem. Cell. Biol."},{"key":"10.1016\/j.drudis.2014.04.014_bib0030","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archpsyc.58.12.1108","article-title":"A circadian signal of change of season in patients with seasonal affective disorder","volume":"58","author":"Wehr","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drudis.2014.04.014_bib0035","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1021\/ja01543a060","article-title":"Isolation of melatonin, the pineal gland factor that lightens melanocytes","volume":"80","author":"Lerner","year":"1958","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drudis.2014.04.014_bib0040","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1111\/j.1742-4658.2006.05322.x","article-title":"Melatonin nature's most versatile signal","volume":"273","author":"Pandi Parumal","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.drudis.2014.04.014_bib0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.smrv.2004.08.001","article-title":"The basic physiology and pathophysiology of melatonin","volume":"9","author":"Claustrat","year":"2005","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.drudis.2014.04.014_bib0050","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1006\/bbrc.1998.9826","article-title":"A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a bio marker of in vivo hydroxyl radical generation","volume":"253","author":"Tan","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drudis.2014.04.014_bib0055","first-page":"96","article-title":"CNS melatonin receptors and signaling: focus on ageing related disease and future perspective","volume":"3","author":"Cavanaugh","year":"2010","journal-title":"Open Neuoendocrinol. J."},{"key":"10.1016\/j.drudis.2014.04.014_bib0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-079X.2009.00701.x","article-title":"Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amine","volume":"47","author":"Hardeland","year":"2009","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.pneurobio.2008.04.001","article-title":"Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways","volume":"85","author":"Pandi-Perumal","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.drudis.2014.04.014_bib0070","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0006-2952(01)00615-3","article-title":"Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3\/QR2. Tissue distribution of MT3\/QR2","volume":"61","author":"Nosjean","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drudis.2014.04.014_bib0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tem.2007.10.007","article-title":"Melatonin in the skin: synthesis, metabolism and functions","volume":"19","author":"Slominski","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2014.04.014_bib0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/ENDO:27:2:101","article-title":"Functional MT1 and MT2 melatonin receptors in mammals","volume":"27","author":"Dubocovich","year":"2005","journal-title":"Endocrine"},{"key":"10.1016\/j.drudis.2014.04.014_bib0085","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.mce.2012.01.004","article-title":"Melatonin membrane receptors in peripheral tissue: distribution and functions","volume":"351","author":"Slominski","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.drudis.2014.04.014_bib0090","first-page":"85","article-title":"Effects of melatonin: basic studies and clinical applications","volume":"7","author":"Yonei","year":"2010","journal-title":"Anti-Ageing Med."},{"key":"10.1016\/j.drudis.2014.04.014_bib0095","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jpi.12090","article-title":"Melatonin and theories of ageing: a critical appraisal of melatonin's role in antiaging mechanism","volume":"55","author":"Hardeland","year":"2013","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1385\/ENDO:27:2:119","article-title":"Antioxidant protection by melatonin","volume":"27","author":"Hardeland","year":"2005","journal-title":"Endocrine"},{"key":"10.1016\/j.drudis.2014.04.014_bib0105","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1749-6632.2001.tb03627.x","article-title":"Free radical-mediated molecular damage: mechanisms for the protective actions of melatonin in the central nervous system","volume":"939","author":"Reiter","year":"2001","journal-title":"Ann. Acad. Sci."},{"key":"10.1016\/j.drudis.2014.04.014_bib0110","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.18388\/abp.2003_3637","article-title":"Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications","volume":"50","author":"Reiter","year":"2003","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.drudis.2014.04.014_bib0115","first-page":"57","article-title":"Melatonin: a potent endogenous hydroxyl radical scavenger","volume":"1","author":"Tan","year":"1993","journal-title":"Endocrine J."},{"key":"10.1016\/j.drudis.2014.04.014_bib0120","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/jpi.12010","article-title":"On the free radical activities of melatonin's metabolites, AFMK and AMK","volume":"54","author":"Glano","year":"2013","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1874360900901010001","article-title":"Melatonin beyond its classical functions","volume":"1","author":"Hardeland","year":"2008","journal-title":"Open Physiol. J."},{"key":"10.1016\/j.drudis.2014.04.014_bib0130","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.yhbeh.2012.02.020","article-title":"Melatonin and mitochondrial dysfunction in central nervous system","volume":"63","author":"Cardinali","year":"2013","journal-title":"Horm. Behav."},{"key":"10.1016\/j.drudis.2014.04.014_bib0135","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1254\/jphs.CPJ04006X","article-title":"Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer's disease","volume":"97","author":"Takuma","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.drudis.2014.04.014_bib0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.eplepsyres.2005.09.057","article-title":"Involvement of nitric oxide pathway in acute anticonvulsant effect in mice","volume":"68","author":"Yahyavi","year":"2006","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1600-079X.1997.tb00341.x","article-title":"Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years\u2019 experience","volume":"23","author":"Carballo","year":"1997","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0150","first-page":"114","article-title":"High dose melatonin therapy for patients with extremely intractable epilepsy","volume":"9","author":"Kazuhiro","year":"2004","journal-title":"Neurol. Asia"},{"key":"10.1016\/j.drudis.2014.04.014_bib0155","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0140-6736(05)79321-1","article-title":"Pro-convulsant effects of oral melatonin in neurologically disabled children","volume":"351","author":"Sheldon","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2014.04.014_bib0160","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/j.0013-9580.2004.17604.x","article-title":"Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial","volume":"45","author":"Gupta","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.drudis.2014.04.014_bib0165","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1365-2826.2003.00989.x","article-title":"Role of melatonin in the regulation of human circadian rhythms and sleep","volume":"15","author":"Cajochen","year":"2003","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.drudis.2014.04.014_bib0170","first-page":"1058","article-title":"Potential action of melatonin in insomnia","volume":"26","author":"Rogers","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.drudis.2014.04.014_bib0175","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1210\/jcem.86.10.7901","article-title":"Melatonin treatment for age related insomnia","volume":"86","author":"Zhdanova","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2014.04.014_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-8-51","article-title":"Nightly treatment of primary insomnia with prolonged release of melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety","volume":"8","author":"Wade","year":"2010","journal-title":"BMC Med."},{"key":"10.1016\/j.drudis.2014.04.014_bib0185","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1517\/13543784.17.10.1567","article-title":"Prolonged release of melatonin for the treatment of insomnia in patient over 55 years","volume":"17","author":"Wade","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.drudis.2014.04.014_bib0190","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-079X.2011.00962.x","article-title":"Melatonin and its analogs in insomnia and depression","volume":"52","author":"Cardinali","year":"2012","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0195","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrd3140","article-title":"Agomelatine, the first melatonergic antidepressant: discovery, characterization and development","volume":"9","author":"Bodinat","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drudis.2014.04.014_bib0200","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.103.051797","article-title":"The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine 2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways","volume":"306","author":"Millan","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2014.04.014_bib0205","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1460-9568.2008.06606.x","article-title":"Circuit projection from suprachiasmatic nucleus to ventral tegmental area: a novel circadian output pathway","volume":"29","author":"Luo","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.drudis.2014.04.014_bib0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2005.11.006","article-title":"Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application","volume":"110","author":"Millan","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2014.04.014_bib0215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1745-7254.2006.00260.x","article-title":"Role of melatonin in Alzheimer-like neurodegeneration","volume":"27","author":"Wang","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.drudis.2014.04.014_bib0220","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0301-0082(99)00023-4","article-title":"The cause of neuronal degeneration in Alzheimer's disease","volume":"60","author":"Vickers","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.drudis.2014.04.014_bib0225","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1034\/j.1600-079x.2002.00841.x","article-title":"Increased melatonin 1-a receptor immunoreactivity in the hippocampus of Alzheimer's disease patient","volume":"32","author":"Savaskan","year":"2002","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0230","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1523\/JNEUROSCI.21-12-04183.2001","article-title":"Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis","volume":"21","author":"Pratico","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drudis.2014.04.014_bib0235","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1749-6632.2000.tb06927.x","article-title":"GSK3 beta forms a tetrameric complex with endogenous PS1-CTF\/NTF and beta-catenin. Effects of the D257\/D385A and FAD-linked mutations","volume":"920","author":"Tesco","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drudis.2014.04.014_bib0240","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-079X.2011.00937.x","article-title":"Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin","volume":"52","author":"Rosales-Corral","year":"2012","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0245","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1745-7254.2006.00267.x","article-title":"Beneficial effects of melatonin in experimental models of Alzheimer disease","volume":"27","author":"Cheng","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.drudis.2014.04.014_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-079X.2012.01014.x","article-title":"A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives","volume":"54","author":"Mauriz","year":"2013","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0255","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/jnr.22201","article-title":"Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model","volume":"88","author":"Tapias","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0260","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-079X.2007.00510.x","article-title":"Melatonin reduces the neuronal loss, down-regulation of dopamine transporter, and up-regulation of D2 receptor in rotenone-induced parkinsonian rats","volume":"44","author":"Lin","year":"2008","journal-title":"J. Pineal. Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0265","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF03033799","article-title":"Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals","volume":"2","author":"Chiueh","year":"2000","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0270","first-page":"45","article-title":"Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process","volume":"19","author":"Gregory","year":"2008","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.drudis.2014.04.014_bib0275","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1526-4610.1989.hed22904242.x","article-title":"Nocturnal plasma melatonin levels in migraine: a preliminary report","volume":"29","author":"Claustrat","year":"1989","journal-title":"Headache"},{"key":"10.1016\/j.drudis.2014.04.014_bib0280","first-page":"383","article-title":"The therapeutic potential of melatonin in migraines and other headache types","volume":"6","author":"Gagnier","year":"2001","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.drudis.2014.04.014_bib0285","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1517\/13543784.15.4.367","article-title":"Potential therapeutic use of melatonin in migraine and other headache disorders","volume":"15","author":"Mario","year":"2006","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.drudis.2014.04.014_bib0290","doi-asserted-by":"crossref","first-page":"61","DOI":"10.48208\/HeadacheMed.2012.14","article-title":"Melatonin in headache disorders","volume":"3","author":"Gocalves","year":"2012","journal-title":"Head. Med."},{"key":"10.1016\/j.drudis.2014.04.014_bib0295","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1468-2982.1997.1704511.x","article-title":"Nocturnal plasma melatonin profile and melatonin kinetics during infusion in status migrainosus","volume":"17","author":"Claustrat","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1016\/j.drudis.2014.04.014_bib0300","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.0022-202X.2005.23686.x","article-title":"Towards dissecting the pathogenesis of retinoid induced hair loss: all trans retinoic acid induces premature hair follicle regression (catagen) by upregulation\u00a0of transforming growth factor-beta2 in the dermal papilla","volume":"124","author":"Foitzik","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.drudis.2014.04.014_bib0305","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2353\/ajpath.2006.050468","article-title":"Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and\/or paracrine promoter of apoptosis driven hair follicle regression","volume":"168","author":"Foitzik","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.drudis.2014.04.014_bib0310","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaad.2004.04.008","article-title":"Evaluation and treatment of male and female pattern hair loss","volume":"52","author":"Olsen","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.drudis.2014.04.014_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-079X.2007.00512.x","article-title":"Melatonin and the hair follicle","volume":"44","author":"Tobias","year":"2008","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0320","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1056\/NEJMoa0808949","article-title":"Functional brown adipose tissue in healthy adults","volume":"360","author":"Virtanen","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2014.04.014_bib0325","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1467-789X.2010.00756.x","article-title":"Significance and application of melatonin in regulation brown adipose tissue metabolism: relation to human obesity","volume":"12","author":"Tan","year":"2011","journal-title":"Obes. Rev."},{"key":"10.1016\/j.drudis.2014.04.014_bib0330","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/jpi.12089","article-title":"Melatonin induces browning of white adipose tissue in Zucker diabetic fatty rats","volume":"55","author":"Aranda","year":"2013","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0335","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.physbeh.2013.04.006","article-title":"Melatonin reduces body weight gain and increase nocturnal activity in male Wistar rats","volume":"118","author":"Terron","year":"2013","journal-title":"Physiol Behav."},{"key":"10.1016\/j.drudis.2014.04.014_bib0340","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.maturitas.2007.06.006","article-title":"Melatonin and estradiol effects on food intake body weight and leptin in ovariectomized rats","volume":"58","author":"Mateos","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.drudis.2014.04.014_bib0345","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/jpi.12100","article-title":"influence of melatonin receptor signalling on parameters involved in blood glucose regulation","volume":"56","author":"Bazwinsky-Wutschek","year":"2014","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0350","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.0808180106","article-title":"Adverse metabolic and cardiovascular consequences\u00a0of circadian misalignment","volume":"106","author":"Scheer","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2014.04.014_bib0355","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1034\/j.1600-079x.2002.10797.x","article-title":"Long-term melatonin administration reduces hyperinsulinemia and improves the altered fatty-acid compositions in type-2 diabetic rats via the restoration of Delta-5 desaturase activity","volume":"32","author":"Nishida","year":"2002","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0360","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1034\/j.1600-079X.2003.00083.x","article-title":"Effect of pinealectomy on plasma levels of insulin and leptin and on hepatic lipids in type 2 diabetic rats","volume":"35","author":"Nishida","year":"2003","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0365","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1600-079X.2006.00415.x","article-title":"Effect of melatonin on cholesterol absorption in rats","volume":"42","author":"Hussain","year":"2007","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0370","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3844\/ajptsp.2011.59.67","article-title":"Effects of melatonin in prevention of neuropathy in STZ-Induced diabetic rats","volume":"6","author":"Nasser","year":"2011","journal-title":"Am. J. Pharmacol. Toxicol."},{"key":"10.1016\/j.drudis.2014.04.014_bib0375","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4239\/wjd.v2.i6.82","article-title":"Role of melatonin on diabetes related disorders","volume":"2","author":"Javier","year":"2011","journal-title":"World J. Diabet."},{"key":"10.1016\/j.drudis.2014.04.014_bib0380","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.exer.2006.10.018","article-title":"Melatonin in the eye: implications for glaucoma","volume":"84","author":"Per","year":"2007","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0385","first-page":"1","article-title":"Melatonin as therapeutic tool in ophthalmology: implications for glaucoma and uveitis","volume":"49","author":"Rosenstein","year":"2010","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0390","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1600-079X.2010.00762.x","article-title":"Melatonin a novel neuroprotectant for glaucoma","volume":"48","author":"Belfort","year":"2010","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0395","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/jpi.12075","article-title":"The role of melatonin in the cells of the innate immunity: a review","volume":"55","author":"Calvo","year":"2013","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0400","first-page":"115","article-title":"Melatonin and its influence on immune system","volume":"6","author":"Szcepanik","year":"2007","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.drudis.2014.04.014_bib0405","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1034\/j.1600-079X.2001.310412.x","article-title":"Melatonin modulates allergic lung inflammation","volume":"31","author":"Eivor","year":"2001","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0410","first-page":"11","article-title":"Disruption of normal circadian rhythms and cardiovascular events","volume":"44","author":"Domindue-Rodrigue","year":"2009","journal-title":"Heart Metab."},{"key":"10.1016\/j.drudis.2014.04.014_bib0415","doi-asserted-by":"crossref","first-page":"671","DOI":"10.33549\/physiolres.931236","article-title":"blood pressure modulation and cardiovascular protection by melatonin: potential mechanism behind","volume":"56","author":"Paulis","year":"2007","journal-title":"Physiol. Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0420","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1034\/j.1600-079X.2002.01860.x","article-title":"Iodomelatonin binding and interaction with beta-adrenergic signaling in chick heart and coronary artery physiology","volume":"32","author":"Pang","year":"2002","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0425","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.lfs.2010.09.011","article-title":"Endothelin-1 as a potential marker of melatonin's therapeutic effects in smoking-induced vasculopathy","volume":"87","author":"Luigi","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.drudis.2014.04.014_bib0430","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1210\/endo.142.11.8464","article-title":"Cyclical regulation of GnRH gene expression in GT1-7 GnRH-secreting neurons by melatonin","volume":"142","author":"Roy","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2014.04.014_bib0435","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1600-079x.2000.280107.x","article-title":"The effect of melatonin on in vitro fertilization and embryo development in mice","volume":"28","author":"Ishizuka","year":"2000","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0440","doi-asserted-by":"crossref","first-page":"38294","DOI":"10.1074\/jbc.M403140200","article-title":"Elatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin","volume":"279","author":"Del","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2014.04.014_bib0445","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1071\/RD12091","article-title":"The rat oocytes synthesizes melatonin","volume":"25","author":"Sakaguchi","year":"2013","journal-title":"Reprod. Fertil. Dev."},{"key":"10.1016\/j.drudis.2014.04.014_bib0450","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1095\/biolreprod.104.039313","article-title":"Serotonin and its antidepressant-sensitive transporter in mouse cumulus-oocyte complexes and embryo","volume":"773","author":"Amireault","year":"2005","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.drudis.2014.04.014_bib0455","first-page":"57","article-title":"Reproductive response of adult Siberian hamsters to one-hour melatonin infusions","volume":"27","author":"Turk","year":"2003","journal-title":"J. Biol."},{"key":"10.1016\/j.drudis.2014.04.014_bib0460","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jneuroim.2013.06.013","article-title":"Melatonin protects mast cells against cytotoxicity mediated by chemical stimuli PMACI: possible clinical use","volume":"262","author":"Maldonado","year":"2013","journal-title":"J. Neuroimmmunol."},{"key":"10.1016\/j.drudis.2014.04.014_bib0465","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.smrv.2008.07.007","article-title":"Melatonin. Sleep disturbance and cancer risk","volume":"13","author":"Blask","year":"2009","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.drudis.2014.04.014_bib0470","first-page":"1","article-title":"An overview of melatonin and breast cancer","volume":"2","author":"Kazor","year":"2010","journal-title":"Nat. Med. J."},{"key":"10.1016\/j.drudis.2014.04.014_bib0475","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-079x.2002.1821.x","article-title":"Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro","volume":"32","author":"Cos","year":"2002","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0480","article-title":"Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission","author":"Hemachandra","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2014.04.014_bib0485","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-079X.2004.00163.x","article-title":"protect effects of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in animal model of Huntington's disease","volume":"37","author":"Tunez","year":"2004","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.drudis.2014.04.014_bib0490","first-page":"343","article-title":"Nomenclature, classification and pharmacology of G-protein coupled melatonin receptors","volume":"62","author":"Dubocovich","year":"2010","journal-title":"Int. Union Basic Clin. Pharmacol. Pharmacol. Rev."},{"key":"10.1016\/j.drudis.2014.04.014_bib0495","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jfca.2012.07.001","article-title":"Comparative evaluation of the antioxidant activity of melatonin and related indoles","volume":"28","author":"Naranjo","year":"2012","journal-title":"J. Food Compos. Anal."},{"key":"10.1016\/j.drudis.2014.04.014_bib0500","first-page":"401343c","article-title":"MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential","author":"Zlotos","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2014.04.014_bib0505","first-page":"661","article-title":"Efficacy of agomelatine, a MT1\/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder","volume":"10","author":"Olie","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.drudis.2014.04.014_bib0510","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0748730404269890","article-title":"Ramelteon (TAK-375) accelerates re entrainment of circadian rhythm after a phase advance of the light-dark cycle in rats","volume":"20","author":"Hirai","year":"2005","journal-title":"J. Biol. Rhythms"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644614001512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644614001512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:18:20Z","timestamp":1761221900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644614001512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":102,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1359644614001512"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2014.04.014","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melatonin: functions and ligands","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2014.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}